News Amid political tumult, a new leader for Europe’s pharma indu... The European pharma industry has appointed a new leader – just as EU politicians face their greatest test in a generation
News OECD calls for 'rebalancing of power' in drug price negotiat... Health systems should fund more treatments for chronic diseases, says EFPIA
Articles EFPIA’s director general, Richard Bergström, on market acces... He says the industry will partner with payers to deliver outcomes-driven, sustainable healthcare, in pharmaphorum's magazine Deep Dive: Market Access.
News Brexit: could European Medicines Agency stay in London? Pharma wants single regulatory system to remain.
News Countdown to European pharma transparency begins EFPIA's Disclosure Code will come into force on June 30.
News Gilead claims first FDA nod for a hepatitis D therapy At its second attempt, Gilead has won FDA approval for chronic hepatitis D virus drug Hepcludex, four years after it was cleared in the EU.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
